SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

UBS Maintains Neutral on Chemours, Raises Price Target to $12

UBS maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $9 to $12.

Benzinga · 05/08/2020 17:02

UBS maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $9 to $12.